BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33580234)

  • 1. Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
    Verrest L; Kip AE; Musa AM; Schoone GJ; Schallig HDFH; Mbui J; Khalil EAG; Younis BM; Olobo J; Were L; Kimutai R; Monnerat S; Cruz I; Wasunna M; Alves F; Dorlo TPC
    Clin Infect Dis; 2021 Sep; 73(5):775-782. PubMed ID: 33580234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
    Verrest L; Monnerat S; Musa AM; Mbui J; Khalil EAG; Olobo J; Wasunna M; Chu WY; Huitema ADR; Schallig HDFH; Alves F; Dorlo TPC
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012078. PubMed ID: 38640118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.
    Verma S; Kumar R; Katara GK; Singh LC; Negi NS; Ramesh V; Salotra P
    PLoS One; 2010 Apr; 5(4):e10107. PubMed ID: 20404924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood parasite load by qPCR as therapeutic monitoring in visceral leishmaniasis patients in Brazil: a case series study.
    Aquino SR; Diniz LFB; Nunes SLP; Silva RLO; Gouveia GV; Gouveia JJS; Sales KGDS; Dantas-Torres F; Carmo RFD
    Rev Soc Bras Med Trop; 2023; 56():. PubMed ID: 36995785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
    Zhang WW; Ghosh AK; Mohamath R; Whittle J; Picone A; Lypaczewski P; Ndao M; Howard RF; Das P; Reed SG; Matlashewski G
    BMC Infect Dis; 2018 Oct; 18(1):500. PubMed ID: 30285653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
    Khalil EA; Weldegebreal T; Younis BM; Omollo R; Musa AM; Hailu W; Abuzaid AA; Dorlo TP; Hurissa Z; Yifru S; Haleke W; Smith PG; Ellis S; Balasegaram M; EL-Hassan AM; Schoone GJ; Wasunna M; Kimutai R; Edwards T; Hailu A
    PLoS Negl Trop Dis; 2014; 8(1):e2613. PubMed ID: 24454970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
    Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters.
    Jara M; Adaui V; Valencia BM; Martinez D; Alba M; Castrillon C; Cruz M; Cruz I; Van der Auwera G; Llanos-Cuentas A; Dujardin JC; Arevalo J
    J Clin Microbiol; 2013 Jun; 51(6):1826-33. PubMed ID: 23554201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
    Kip AE; Wasunna M; Alves F; Schellens JHM; Beijnen JH; Musa AM; Khalil EAG; Dorlo TPC
    Front Cell Infect Microbiol; 2018; 8():181. PubMed ID: 29911074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.
    Molina I; Fisa R; Riera C; Falcó V; Elizalde A; Salvador F; Crespo M; Curran A; López-Chejade P; Tebar S; Pérez-Hoyos S; Ribera E; Pahissa A
    Am J Trop Med Hyg; 2013 Jul; 89(1):105-10. PubMed ID: 23629932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis.
    Sudarshan M; Weirather JL; Wilson ME; Sundar S
    J Antimicrob Chemother; 2011 Aug; 66(8):1751-5. PubMed ID: 21609983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.
    Ramesh V; Dixit KK; Sharma N; Singh R; Salotra P
    J Infect Dis; 2020 Feb; 221(4):608-617. PubMed ID: 31854451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Quantitative PCR in the Diagnosis and Evaluating Treatment Efficacy of Leishmaniasis.
    Wu Y; Tian X; Song N; Huang M; Wu Z; Li S; Waterfield NR; Zhan B; Wang L; Yang G
    Front Cell Infect Microbiol; 2020; 10():581639. PubMed ID: 33117735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasite load in the blood and skin of dogs naturally infected by Leishmania infantum is correlated with their capacity to infect sand fly vectors.
    Borja LS; Sousa OMF; Solcà MDS; Bastos LA; Bordoni M; Magalhães JT; Larangeira DF; Barrouin-Melo SM; Fraga DBM; Veras PST
    Vet Parasitol; 2016 Oct; 229():110-117. PubMed ID: 27809965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Correlative Study of Splenic Parasite Score and Peripheral Blood Parasite Load Estimation by Quantitative PCR in Visceral Leishmaniasis.
    Sudarshan M; Singh T; Chakravarty J; Sundar S
    J Clin Microbiol; 2015 Dec; 53(12):3905-7. PubMed ID: 26400788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro growth of Leishmania parasites from biopsy samples of suspected cutaneous and visceral leishmaniasis cases in Sri Lanka: An observational study.
    Deepachandi B; Weerasinghe S; Gunathileka H; Soysa P; Siriwardana Y
    Exp Parasitol; 2024 Apr; 259():108710. PubMed ID: 38350521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
    Hossain F; Ghosh P; Khan MAA; Duthie MS; Vallur AC; Picone A; Howard RF; Reed SG; Mondal D
    PLoS One; 2017; 12(9):e0185606. PubMed ID: 28957391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
    Opota O; Balmpouzis Z; Berutto C; Kaiser-Guignard J; Greub G; Aubert JD; Prod'hom G; Manuel O; Jaton K
    Transpl Infect Dis; 2016 Oct; 18(5):801-804. PubMed ID: 27495987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.